IL127033A - Method for early detection of lysosomal storage disorders and a kit for detecting the same - Google Patents

Method for early detection of lysosomal storage disorders and a kit for detecting the same

Info

Publication number
IL127033A
IL127033A IL12703397A IL12703397A IL127033A IL 127033 A IL127033 A IL 127033A IL 12703397 A IL12703397 A IL 12703397A IL 12703397 A IL12703397 A IL 12703397A IL 127033 A IL127033 A IL 127033A
Authority
IL
Israel
Prior art keywords
lysosomal storage
storage disorders
kit
detecting
same
Prior art date
Application number
IL12703397A
Other languages
English (en)
Other versions
IL127033A0 (en
Original Assignee
Women S And Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Women S And Childrens Hospital filed Critical Women S And Childrens Hospital
Publication of IL127033A0 publication Critical patent/IL127033A0/xx
Publication of IL127033A publication Critical patent/IL127033A/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
IL12703397A 1996-05-17 1997-05-16 Method for early detection of lysosomal storage disorders and a kit for detecting the same IL127033A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPN9917A AUPN991796A0 (en) 1996-05-17 1996-05-17 Early detection of lysosomal storage disorders
PCT/AU1997/000304 WO1997044668A1 (en) 1996-05-17 1997-05-16 Early detection of lysosomal storage disorders

Publications (2)

Publication Number Publication Date
IL127033A0 IL127033A0 (en) 1999-09-22
IL127033A true IL127033A (en) 2000-12-06

Family

ID=3794228

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12703397A IL127033A (en) 1996-05-17 1997-05-16 Method for early detection of lysosomal storage disorders and a kit for detecting the same

Country Status (10)

Country Link
US (2) US6759189B1 (xx)
EP (1) EP1021725B1 (xx)
JP (3) JP3837711B2 (xx)
AT (1) ATE426169T1 (xx)
AU (1) AUPN991796A0 (xx)
CA (2) CA2253875C (xx)
DE (1) DE69739317D1 (xx)
IL (1) IL127033A (xx)
NZ (1) NZ332641A (xx)
WO (1) WO1997044668A1 (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7090987B1 (en) 1999-04-30 2006-08-15 Nixon Ralph A Methods for the identification of compounds for the treatment of neuronal atrophy-associated dementia
CA2372190A1 (en) * 1999-04-30 2000-11-09 The Nathan S. Kline Institute For Psychiatric Research Methods for the treatment of neuronal atrophy-associated dementia
US8173443B2 (en) 2003-03-31 2012-05-08 Women's And Children's Hospital Multiplex screening for lysosomal storage disorders (LSDs)
US7615224B2 (en) 2004-12-02 2009-11-10 Women's And Children's Hospital Multiplex-bead complex for determination of lysosomal storage disorders
ES2301280A1 (es) * 2005-05-16 2008-06-16 Fina Biotech S.L.U. Metodo para diagnosticar la enfermedad de alzheimer.
WO2007136782A2 (en) * 2006-05-19 2007-11-29 Historx, Inc. Kits and methods for evaluating misfolded proteins
WO2008070892A1 (en) * 2006-12-13 2008-06-19 Tgr Biosciences Pty Ltd Promoting production of extracellular matrix by fibroblast cells and/or promoting migration of fibroblast cells
WO2009114679A2 (en) * 2008-03-12 2009-09-17 Amicus Therapeutics, Inc Treatment of pompe disease with specific pharmacological chaperones and monitoring treatment using surrogate markers
US8497122B2 (en) * 2008-04-11 2013-07-30 Washington University Biomarkers for Niemann-pick C disease and related disorders
GB201114909D0 (en) * 2011-08-30 2011-10-12 San Raffaele Centro Fond Biomarkers for lysosomal storage disorders
US8293487B1 (en) * 2012-01-06 2012-10-23 Jiandi Zhang Zestern, a simple, fast, specific and quantifiable improvement of immunodetection process
WO2014153083A1 (en) 2013-03-14 2014-09-25 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Compositions and methods for predicting age of onset of a lysosomal storage disease or a disease associated with a lysosomal defect
US12020820B1 (en) 2017-03-03 2024-06-25 Cerner Innovation, Inc. Predicting sphingolipidoses (fabry's disease) and decision support
US11335461B1 (en) 2017-03-06 2022-05-17 Cerner Innovation, Inc. Predicting glycogen storage diseases (Pompe disease) and decision support
US11923048B1 (en) 2017-10-03 2024-03-05 Cerner Innovation, Inc. Determining mucopolysaccharidoses and decision support tool

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859581A (en) * 1986-03-10 1989-08-22 Board Of Regents, The University Of Texas System Endoglycosidase assay
AU2990692A (en) 1991-12-06 1993-06-10 Commonwealth Scientific And Industrial Research Organisation Diagnostic method for pompe's disease
WO1994010340A1 (en) 1992-10-30 1994-05-11 Mt. Sinai Hospital Corporation Method for measuring glycosyltransferase activity

Also Published As

Publication number Publication date
IL127033A0 (en) 1999-09-22
JP2008289501A (ja) 2008-12-04
EP1021725A4 (en) 2002-10-30
CA2253875A1 (en) 1997-11-27
JP3837711B2 (ja) 2006-10-25
EP1021725A1 (en) 2000-07-26
DE69739317D1 (de) 2009-04-30
AUPN991796A0 (en) 1996-06-13
ATE426169T1 (de) 2009-04-15
CA2731490A1 (en) 1997-11-27
CA2253875C (en) 2011-02-22
NZ332641A (en) 2000-05-26
EP1021725B1 (en) 2009-03-18
US20040191847A1 (en) 2004-09-30
WO1997044668A1 (en) 1997-11-27
US6759189B1 (en) 2004-07-06
JP4260152B2 (ja) 2009-04-30
JP2006061161A (ja) 2006-03-09
JP2001519894A (ja) 2001-10-23

Similar Documents

Publication Publication Date Title
IL127033A0 (en) A method for early detection of lysosomal storage disorders and a kit for detecting the same
CA2160916A1 (en) Test composition for the rapid detection of helicobacter pylori in gastric biopsy tissue
WO1999049807A3 (en) A device and method for performing a biological modification of a fluid
DK0944731T3 (da) Enzymsensor
CA2421007A1 (en) Method for detection of htr and htert telomerase-associated rna in plasma or serum
WO2002040634A3 (en) Expression miniarrays and uses thereof
CA2229271A1 (en) Compositions containing hydroxy acids or retinoids
PT823993E (pt) Microcapsulas sensiveis ao ph
BR0208597A (pt) Meio de detecção de staphylococcus aureus e/ou estafilococos com coagulose positiva e método de identificação de bactéria (s) da espécie staphylococcus aureus em uma amostra
CA2213709A1 (en) Novel methods for diagnosing benign prostatic diseases
EP0630974A3 (en) Method and test kit for the detection of inorganic orthophosphate in the amplification of target nucleic acids.
ES8607243A1 (es) Esteres de aminoacidos y de peptidos cromogenos
CA2317816A1 (en) Peptide detection method
EP0924523A3 (de) Verfahren und Diagnosemittel zum Nachweis von Hämostasestörungen
CA2339821A1 (en) Enzymatic measurement of mycophenolic acid
MY101096A (en) Compositions and methods for the detection of urease for the diagnosis of campylobacter pyloridis infection.
BG103098A (en) Colour composition including an agent contaning pyrogalols, salt of iron (ii) and organic acid
WO2003001182A3 (en) Homocysteinylated transthyretin
WO1998050576A8 (en) Betaines as adjuvants to susceptibility testing and antimicrobial therapy
NO974801L (no) Koldrengjöringspreparater basert på alkaner eller cykloalkaner og en organisk forbindelse omfattende en ketongruppe
WO1999001567A3 (en) Methods and compositions for a deubiquitinating enzyme and variants thereof
WO1998051782A3 (en) Human 3-hydroxyisobutyryl-coenzyme a hydrolase
ES8801810A1 (es) Un procedimiento para la preparacion de sustratos derivados de xantilio.
ES2160491A1 (es) Secuencia aminoacida apta para afectar la actividad enzimatica de pectin metilesterasas (pme) y secuencia nucleotica para enzimas que afectan petin metilesterasas comprendiendo dicha secuencia aminoacida.
AU2158001A (en) Detection of peroxidases

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees